{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["29(2)"],"submitter":["Ghosn J"],"pubmed_abstract":["<h4>Objectives</h4>Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort.<h4>Methods</h4>Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender.<h4>Results</h4>We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Me"],"journal":["Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases"],"pagination":["254.e7-254.e13"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9523945"],"repository":["biostudies-literature"],"pubmed_title":["Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort."],"pmcid":["PMC9523945"],"pubmed_authors":["Liegeon G","Bachelet D","Gandonniere CS","Maillet M","Zucman D","Goehringer F","Bani-Sadr F","Laouenan C","Chirouze C","Martin-Blondel G","Yelnik C","Surgers L","Roger PM","Cervantes-Gonzalez M","Livrozet M","Launay O","French COVID cohort Study Group and the French COVID cohort Investigators Group","Poissy J","Duval X","Senneville E","Ghosn J","Faure K","Gousseff M","Dudoignon E","Joseph C","Cabie A","Tattevin P"],"additional_accession":[]},"is_claimable":false,"name":"Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.","description":"<h4>Objectives</h4>Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort.<h4>Methods</h4>Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender.<h4>Results</h4>We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Me","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2026-06-01T02:23:39.81Z","creation":"2025-04-05T22:22:36.203Z"},"accession":"S-EPMC9523945","cross_references":{"pubmed":["36191847"],"doi":["10.1016/j.cmi.2022.08.028"]}}